Reaction

Dementia Alzheimer'S Type reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,673 reports · 19 co-occurring drugs

As of the last recalculation, Dementia Alzheimer'S Type appears in 1,673 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is RIVASTIGMINE (PRR 116.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Rivastigmine160116.7117.7
Donepezil Hydrochloride14754.554.8
Valsartan And Hydrochlorothiazide2927.027.1
Extended Phenytoin Sodium2015.015.1
Raloxifene Hydrochloride1714.614.6
Quetiapine18713.513.5
Captopril1013.013.0
Memantine1412.812.8
Memantine Hydrochloride1412.812.8
Ziprasidone Mesylate1311.411.4
Amlodipine Besylate And Benazepril Hydrochloride810.810.8
Insulin Human3210.210.2
Olanzapine Pamoate319.69.6
Amlodipine Besylate And Valsartan89.09.0
Ziprasidone128.58.5
Teriparatide404.54.5
Romiplostim54.14.1
Gefitinib34.14.1
Conjugated Estrogens And Medroxyprogesterone Acetate73.73.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.